scholarly article | Q13442814 |
P2093 | author name string | Kawakami M | |
Kawakami K | |||
Puri RK | |||
Joshi BH | |||
P433 | issue | 16 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | interleukins | Q194908 |
P304 | page(s) | 6194-6200 | |
P577 | publication date | 2001-08-01 | |
P1433 | published in | Cancer Research | Q326097 |
P1476 | title | Interleukin-13 receptor-targeted cancer therapy in an immunodeficient animal model of human head and neck cancer | |
P478 | volume | 61 |
Q36108466 | Affitoxin--a novel recombinant, HER2-specific, anticancer agent for targeted therapy of HER2-positive tumors |
Q37970682 | Challenges in immunotherapy presented by the glioblastoma multiforme microenvironment |
Q36295853 | Chemopreventive and chemotherapeutic actions of mTOR inhibitor in genetically defined head and neck squamous cell carcinoma mouse model. |
Q37390393 | Effect of treatment on systemic cytokines in head and neck squamous cell carcinoma patients |
Q35847498 | Hodgkin lymphoma therapy with interleukin-4 receptor-directed cytotoxin in an infiltrating animal model |
Q36545018 | IL-13 receptor α2 is a negative prognostic factor in human lung cancer and stimulates lung cancer growth in mice |
Q36926747 | Identification of interleukin-13 receptor alpha2 chain overexpression in situ in high-grade diffusely infiltrative pediatric brainstem glioma |
Q36369794 | In vivo overexpression of IL-13 receptor alpha2 chain inhibits tumorigenicity of human breast and pancreatic tumors in immunodeficient mice |
Q35789233 | Interleukin-13 fusion cytotoxin arrests Schistosoma mansoni egg-induced pulmonary granuloma formation in mice |
Q90195010 | Interleukin4Rα (IL4Rα) and IL13Rα1 Are Associated with the Progress of Renal Cell Carcinoma through Janus Kinase 2 (JAK2)/Forkhead Box O3 (FOXO3) Pathways |
Q36863089 | MicroRNA-135b acts as a tumor promoter by targeting the hypoxia-inducible factor pathway in genetically defined mouse model of head and neck squamous cell carcinoma |
Q28571784 | Molecular cloning of the rat IL-13 alpha 2 receptor cDNA and its expression in rat tissues |
Q26850237 | Nucleic acid targeting: towards personalized therapy for head and neck cancer. |
Q37078999 | Prioritization schema for immunotherapy clinical trials in glioblastoma |
Q36686360 | Targeting of interleukin-13 receptor α2 for treatment of head and neck squamous cell carcinoma induced by conditional deletion of TGF-β and PTEN signaling |
Q33525571 | Therapeutic efficacy of Cintredekin Besudotox (IL13-PE38QQR) in murine lung fibrosis is unaffected by immunity to Pseudomonas aeruginosa exotoxin A. |
Q35942450 | Therapeutic targeting of IL-4- and IL-13-responsive cells in pulmonary fibrosis |
Q27006226 | Toxin-based targeted therapy for malignant brain tumors |
Q48303412 | Tumor targeted delivery of doxorubicin in malignant peripheral nerve sheath tumors. |
Search more.